Emergent Biosolutions Inc. · NYSE:EBS
BlackRock, Inc. reported a 7.30% stake in Emergent Biosolutions Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 7.30% stake in Emergent Biosolutions Inc., 3,977,535 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 7.30%
- Shares
- 3,977,535
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.30% | 3,977,535 |
Source
Related
- Emergent Biosolutions Inc.
- BlackRock, Inc.
- Emergent Biosolutions Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · DeGolyer Donald W · Oct 7, 2026
- Form 4 · Williams Paul Anthony · Oct 5, 2026
- Schedule 13G · American Century Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Williams Paul Anthony · Jul 2, 2026